Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome

Clinical trial NCT01438853 · COMPLETED

Trial details

NCT number: NCT01438853
Sponsor: Altor BioScience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sepsis Acute Lung Injury Acute Respiratory Distress Syndrome

Start date: 2004-12-01
Primary completion: 2006-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.